Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

973
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
973
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A disentangled transformer-based transfer learning framework to predict patient drug response from tumor single-cell transcriptomics.

Bioinformatics (Oxford, England)·2026
Same author

Bridging the evidence gap: three-year BCG maintenance therapy shows enhanced protection over one-year regimen in Chinese NMIBC.

World journal of surgical oncology·2026
Same author

FluNexus: A versatile web platform for antigenic prediction and visualization of influenza A viruses.

iMeta·2026
Same author

RAREsim2: flexible simulation of rare variant genetic data using real haplotypes.

Bioinformatics (Oxford, England)·2026
Same author

Epidemiological Features and Temporal Trends of Five Common Sexually Transmitted Infections Excluding HIV, 1990-2021: Findings From the Global Burden of Disease Study.

Journal of medical virology·2026
Same author

Mosaic integration of spatial multi-omics with SpaMosaic.

Nature genetics·2026
Same journal

DeepDPM: A Deep Learning Method for MoRFs Prediction Based on Wavelet Transform and Dynamic Convolutional Attention Mechanism.

Journal of chemical information and modeling·2026
Same journal

Graph-Based Generation and Reduction of Complex Chemical Reaction Networks.

Journal of chemical information and modeling·2026
Same journal

Modeling the Sensitivity of Large-Scale Virtual Screening to Scoring Function Accuracy, Artifacts, and Library Composition.

Journal of chemical information and modeling·2026
Same journal

Machine Learning-Driven Discovery of Indole/Oxoindole-Piperazine Scaffolds as Dual MAO-B/Sig-1R Ligands for Neurodegenerative Disorders.

Journal of chemical information and modeling·2026
Same journal

Mapping Evolution of Molecules across Biochemistry with Assembly Theory.

Journal of chemical information and modeling·2026
Same journal

Structural Proteomics-Based Deciphering of Hydrophobic Packing Fingerprints Informing Protein Thermostability in TIM Barrels.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning.

Xiang Du1,2, Xinliang Sun1, Min Li1

  • 1School of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.

Journal of Chemical Information and Modeling
|June 5, 2024
PubMed
Summary
This summary is machine-generated.

Drug repositioning accelerates drug discovery by repurposing existing drugs for new uses. Our KGCNH model effectively predicts drug-disease associations using biomedical knowledge graphs and heuristic search, outperforming existing methods.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

Related Experiment Videos

Last Updated: Jun 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

Area of Science:

  • Biomedical informatics
  • Computational biology
  • Drug discovery

Background:

  • Drug repositioning offers a cost-effective and safer alternative to traditional drug development.
  • Biomedical knowledge graphs integrate diverse data, presenting opportunities for advanced drug repositioning strategies.
  • Existing methods may not fully leverage the semantic and topological information within complex biological knowledge graphs.

Purpose of the Study:

  • To propose a novel Knowledge Graph Convolutional Network with Heuristic Search (KGCNH) for predicting drug-disease associations.
  • To enhance the utilization of semantic and topological information from biomedical knowledge graphs.
  • To improve the accuracy and robustness of drug repositioning predictions.

Main Methods:

  • Developed a relation-aware attention mechanism to weigh neighboring entities based on relations.
  • Implemented a Gumbel-Softmax-based heuristic search module to explore optimal drug and disease embeddings.
  • Utilized neighborhood aggregation for entity embedding and employed feature-based augmented views for model regularization.

Main Results:

  • KGCNH demonstrated superior performance compared to existing methods on two benchmark datasets.
  • Case studies involving lithium and quetiapine validated KGCNH's ability to identify actual drug-disease associations.
  • The model effectively captures both semantic and topological features from biomedical knowledge graphs.

Conclusions:

  • KGCNH provides an effective framework for drug repositioning by leveraging biomedical knowledge graphs.
  • The proposed heuristic search and attention mechanisms enhance the prediction of drug-disease associations.
  • This approach holds significant potential for accelerating the identification of new therapeutic indications for existing drugs.